|
From September 2006 to October 2007 Dr. Brawer was Threshold's interim CMO. Dr. Brawer oversaw strategic product development for the Company's pipeline of clinical product candidates. Dr. Brawer is the winner of several prestigious awards including the 1996 Gold Cystoscope Award for outstanding contributions to the profession from the American Urological Association. He has been the principal investigator or consultant for more than 90 studies supported through national research and industry grants. The objective of his research has been basic science and clinical investigations into benign and neoplastic proliferative disorders of the prostate. Dr. Brawer received his medical degree from the University of California School of Medicine and completed his internship and residency training at Stanford University School of Medicine. He serves on the editorial review boards of 13 medical journals and has served on the scientific advisory boards of many pharmaceutical and medical device companies. | 